Matthew J. Friedman, MD
Professor of Psychiatry
Dartmouth College, AB 1961
Einstein College of Medicine, PHD 1967
U. Kentucky, MD 1969
Neuroscience Center at Dartmouth
Dartmouth Medical School
Hanover NH 03755
Dr. Matthew J. Friedman received his Ph.D. in pharmacology at the Albert Einstein College of Medicine in 1967. He then received an M.D. at the University of Kentucky, Lexington where he also had a post-doctoral fellowship, served on the faculty of the Department of Pharmacology and had a rotating internship. His residency in psychiatry was at the Massachusetts General Hospital (1970-1972) and at the Dartmouth-Hitchcock Medical Center (1972-1973). He joined the Dartmouth faculty in Psychiatry in 1973 and in Pharmacology and Toxicology in 1976. His major clinical assignment has been at the VA Medical Center, White River Junction, where he served as staff psychiatrist (1973-1978), and Chief of Psychiatry (1978-1989). He has been Executive Director of the U. S. Department of Veterans Affairs National Center for Post-Traumatic Stress Disorder (PTSD) and Professor of Psychiatry and of Pharmacology and Toxicology at Dartmouth Medical School. He has worked with PTSD patients as a clinician and researcher for thirty-five years and has published extensively on stress and PTSD, biological psychiatry, psychopharmacology, and clinical outcome studies on depression, anxiety, schizophrenia, and chemical dependency. He has over 200 publications, including seventeen books and monographs. Listed in The Best Doctors in America, he is a Distinguished Lifetime Fellow of the American Psychiatric Association, past-president of the International Society for Traumatic Stress Studies (ISTSS), Chair of the scientific advisory board of the Anxiety Disorders Association of America and has served on many VA, DoD and NIMH research, education and policy committees. He has received many honors including the ISTSS Lifetime Achievement Award in 1999.
Re-Engineering Systems for Primary Care Treatment of PTSD ($1,242,100) 2007-2009. VA HSR&D. Schnurr PP & Friedman MJ, co-principal investigators
PTSD/TBI Clinical Consortium Study Site Award ($1,500,000) 2008-2013. DoD CDMRP. McAllister TW & Friedman MJ, co-principal investigators
Lecture medical students in SBM on PTSD
Teach seminars to psychiatry residents on the neurobiology and pharmacological treatment of PTSD.
Decoding Shared Versus Divergent Transcriptomic Signatures Across Cortico-Amygdala Circuitry in PTSD and Depressive Disorders.
Risk factors for suicide in the Vietnam-era twin registry.
Comparison of Prolonged Exposure vs Cognitive Processing Therapy for Treatment of Posttraumatic Stress Disorder Among US Veterans: A Randomized Clinical Trial.
Instruments for Measuring Violence on Acute Inpatient Psychiatric Units: Review and Recommendations.
Increased Smoking Cessation Among Veterans With Large Decreases in Posttraumatic Stress Disorder Severity.
Does COVID-19 count?: Defining Criterion A trauma for diagnosing PTSD during a global crisis.
Improving the Assessment of COVID-19-Associated Posttraumatic Stress Disorder.
Transcriptomic organization of the human brain in post-traumatic stress disorder.
PTSD improvement and substance use disorder treatment utilization in veterans: Evidence from medical record data.
PTSD improvement and incident cardiovascular disease in more than 1000 veterans.